title: Corticosteroid therapy for the treatment of optic neuritis.
abstract: Optic neuritis is frequently the first clinical sign of multiple sclerosis (MS). Study results indicate that methylprednisolone pulse therapy reduces the rate of development of MS over a two year period. Patients also experience quicker recovery of vision. This short duration therapy presents immediate and intense nursing care challenges. Coordination of care between three departments at the University of Michigan Medical Center enables many patients to complete IV [intravenous] pulse therapy at home. Although coordination is challenging for providers, ambulatory care and home care benefit patients and their families with potential healthcare cost savings.
authors.forename: K
authors.initials: K
authors.lastname: Brewer
authors.forename: S
authors.initials: S
authors.lastname: Fraker
authors.forename: S
authors.initials: S
authors.lastname: Krolicki
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D018718:Home Infusion Therapy / Q000451:nursing*; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D009902:Optic Neuritis / Q000188:drug therapy* / Q000451:nursing; D017410:Practice Guidelines as Topic
chemical_list: D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone